448 results about "Alisma plantago" patented technology

The invention discloses a Chinese medicinal composition for treating jaundice and a preparation method thereof. The Chinese medicinal composition of the invention mainly comprises the following raw material medicaments: virgate wormwood herb, Indian buead, plantain seed, oriental waterplantain rhizome, lalang grass rhizome, vine root, heartleaf houttuynia herb, coix seed, talc, ricepaperplant pith, belvedere fruit, pyrrosia leaf, longhairy antenoron herb, giant knotweed rhizome, tangerine peel, costus root, rhubarb, gypsum, anemarrhena asphodeloides bunge, mongolian snakegourd root, common lophatherum herb, gardenia, unprepared rehmannia root, seed of feather cockscomb, common selfheal fruit-spike, figwort root, tree peony bark, honeysuckle flower, dandelion and the like. The Chinese medicinal composition of the invention can be prepared into any common oral preparation by the conventional Chinese medicinal preparation method. The Chinese medicinal composition has the advantages of capability of remarkably improving symptoms such as jaundice, hypodynamia, discomfort, skin itch, skin yellowing, deep urea color, fever, epigastralgia, hepatomegaly and the like, determined clinical curative effect, remarkable curative effect, quick response, low cost, basically no toxic or side effect and the like.

The invention discloses a new Chinese medicine composite for treatment of acute gastroenteritis and a preparation method thereof. The Chinese medicine composite of the invention mainly comprises the following materials of tuckahoe, magnolia officinalis, rhizoma atractylodis macrocephalae, plantain seed, dried ginger, rhizoma pinelliae, styrax, medicated leaven, fructus hordei germinatus, semen arecae prepareta, endothelium corneum gigeriae galli, rhizoma corydalis, medicinal evodia fruit, cassia, fructus quisqualis, pericarpium citri reticulatae, rhizoma coptidis, oriental water plantain rhizome, cortex periplocae radicis, taraxacum, bunge corydalis herb , pollen typhae carbonisatus, honeysuckle flower, jobstears seed, and the like. The Chinese medicine composite of the invention can be prepared into any common oral preparation according to the conventional Chinese medicine preparation method. The composite can obviously improve nausea, emesis, abdominal pain, diarrhea, fever, and the like. The serious patient may have symptoms of dehydration, electrolyte disturbance, shock bowel, septicemia and the like. The composite has reliable and apparent clinical effect and fast desired effect. Due to the combination of the medicines both as food and medicine according to state-promulgated pharmacopoeia, the Chinese medicine composite of the invention has the advantages of low cost and no toxic and side effect basically.

The invention discloses a semen cassiae, fructus lycii and glossy privet fruit oral solution with functions of tonifying liver and reducing fat. The semen cassiae, fructus lycii and glossy privet fruit oral solution is prepared by adopting the steps of respectively weighing Chinese medicinal herbs: 30 parts of semen cassia, 30 parts of fructus lycii, 30 parts of glossy privet fruit, 20 parts of polygonum multiflorum thumb, 20 parts of gynostemma pentaphylla, 20 parts of raw hawthorn, 20 parts of capillary artemisia, 10 parts of radix curcumae and 10 parts of rhizoma alismatis; and decocting the Chinese medicinal herbs together according to a conventional method, and densely decocting into an oral solution of 2g dried medicinal herbs / ml. A taking method is as follows: the semen cassiae, fructus lycii and glossy privet fruit oral solution is taken twice, 20ml per time. One month is a course of treatment, and the semen cassiae, fructus lycii and glossy privet fruit oral solution is generally taken for three courses of treatment. Fatty, sweet, stodgy and pungent foods are contraindicated in a taking process. The semen cassiae, fructus lycii and glossy privet fruit oral solution has the advantages of low Chinese medicinal herb price, and is convenience to take and process, and has a remarkable treatment effect on non-alcoholic fatty liver disease and hyperlipoidemia. Meanwhile, according to the characteristic of liver deficiency, the semen cassiae, fructus lycii and glossy privet fruit oral solution is suitable for all types of syndrome of the traditional Chinese medicine, is capable of recovering the function of the liver to protect the liver and is capable of removing pathological products to achieve the treatment purpose.

The invention provides a pharmaceutical composition for treating alcoholic liver diseases. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 172-258 parts of flower of kudzuvine, 128.8-193.2 parts of root of codonopsis pilosula, 85.6-128.4 parts of bighead atractylodes rhizome, 85.6-128.4 parts of poria cocos, 85.6-128.4 parts of bupleurum, 128.8-193.2 parts of white peony root, 128.8-193.2 parts of salviae miltiorrhizae, 128.8-193.2 parts of polygonum cuspidatum, 128.8-193.2 parts of rhizoma alismatis, 128.8-193.2 parts of hawthorn fruit, 128.8-193.2 parts of penthorum chinense pursh, 128.8-193.2 parts of hovenia dulcis thumb and 43.2-64.8 parts of liquorice. The invention also provides a preparation method and application of the pharmaceutical composition. The pharmaceutical composition disclosed by the invention is used for treating the diseases caused by alcoholic abuse and dependency, such as mild alcoholic injury, alcoholic fatty liver and alcoholic hepatitis, has good effects of dispelling the effects of alcohol, protecting the liver and lowering lipid and is obvious in curative effect of treating the alcoholic liver diseases. In addition, the medicine can obviously shorten the alcohol effect dispelling time by about 2 hours and is stable and reliable in drug effect and convenient to carry and take, and a novel selection is provided for clinical application.

The invention discloses a medicine for treating Qi-stagnation and blood stasis type chloasma and a preparation method thereof. The medicine is prepared by eclipta, caulis sargentodoxae, large-leaved gentian, gynostemma pentaphylla, fructus aurantii, nux prinsepiae, testiset penis phocae, iris ensata thumb, hippocampus, angelica, rhizoma sparganii, curcuma zedoary, rhizome of glabrous greenbrier, moutan bark, rhizoma alismatis, rhizoma anemarrhenae, corydalis bowerihemsl., cortex phellodendri, cortex lycii radicis, herba melastomatis dodecandri, bamboo fern, pericarpium citri reticulatae, kohlrabi, rhizoma cyperi, melastoma sanguineum, radix paeoniae rubra, impure mirabilite, polygonum sagittatum, euphorbia maculata, tuber fleeceflower stem, rubus hirsutus and viola variegate. The medicine provided by the invention has the effects of regulating vital energy and promoting blood flow and removing stasis and ecchymoses, is mainly used for treating the Qi-stagnation and blood stasis type chloasma, and has the advantages of being fast to take effect, high in effective rate, definite in curative effect, short in treatment course, low in price, and is free from toxic and side effects.

The invention discloses a Chinese medicinal composition for treating cerebraledema and a preparation method thereof and belongs to the field of Chinese medicaments. The Chinese medicinal composition of the invention comprises the following raw materials in portion by weight: agaric 9-12, Indian buead 9-12, larger head atractylodes rhizome 9-12, oriental waterplantain rhizome 12-15, cassia bark 3-6, stiff silkworm 6-9, cicada slough 6-9, turmeric 1-3, rhubarb 2-4, hiraute shiny bugleweed herb 12-15, plantain seed 5-9, and leech 2-4. With the characteristics of regulating the ascending and descending of qi dynamic and disinhibiting water by bland percolation, the Chinese medicinal composition can effectively correct pathologic factors of oedema in the central nervous system and treat stroke caused by abnormal circulation of qi and blood in brain. The Chinese medicinal composition of the invention is safe in clinic use, avoids any adverse reaction in patients after use, effectively protects the functions of the kidney of the patient with cerebral apoplexy and avoids any adverse reaction generating in patients stopping using the medicament.